ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone for Asthma

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 29, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Oct. 29, 2024 -- For patients with asthma, inhaled corticosteroids (ICS) combined with short-acting β agonists (SABA) and ICS combined with the long-acting β agonist formoterol are each associated with reduced asthma exacerbations compared with SABA alone, according to a study published online Oct. 28 in the Journal of the American Medical Association. The study was published to coincide with the annual meeting of the American College of Allergy, Asthma & Immunology, held from Oct. 24 to 28 in Boston.

Daniel G. Rayner, from McMaster University in Hamilton, Ontario, Canada, and colleagues conducted a systematic review to compare SABA alone to SABA combined with ICS and with fast-onset formoterol combined with ICS for asthma. Data were included from 27 randomized clinical trials with 50,496 adult and pediatric patients.

The researchers found that both ICS-containing relievers were associated with fewer severe exacerbations compared with SABA alone (risk ratios, 0.65 and 0.84 for ICS-formoterol and ICS-SABA, respectively), with high certainty. Both ICS-containing relievers were associated with improved asthma control compared with SABA alone (risk ratio improvement in total score, 1.07 and 1.09 for ICS-formoterol and ICS-SABA, respectively), with high certainty. ICS-formoterol and ICS-SABA were not associated with an increased risk for serious adverse events compared with SABA alone (high and moderate certainty, respectively).

"ICS combined with formoterol and ICS combined with SABA were each associated with reduced asthma exacerbations and improved asthma control compared with SABA alone," the authors write.

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-30 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords